Nevirapine Extended Release
- Product NDC
- 47781-317
- 11-digit product format
- 477810317
- Labeler code
- 47781
- Product ID
- 47781-317_305214ec-3418-87fa-6140-35c919e67bff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- nevirapine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Alvogen Inc.
- Application
- ANDA204621
- Marketing category
- ANDA
- Marketing start
- 2015-07-14
- Marketing end
- 0000-00-00
- Substance
- NEVIRAPINE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-317-30 | 47781031730 | 30 TABLET in 1 BOTTLE (47781-317-30) | 30 tablet | 2015-07-14 | 0000-00-00 | No | No | Current |